Review



ipilimumab  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress ipilimumab
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Ipilimumab, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ipilimumab/product/MedChemExpress
    Average 93 stars, based on 5 article reviews
    ipilimumab - by Bioz Stars, 2026-03
    93/100 stars

    Images

    1) Product Images from "CIK-augmented anti-PD1/CTLA4 immunotherapy eradicates chemo-resistant ovarian cancer via tripartite mechanistic synergy"

    Article Title: CIK-augmented anti-PD1/CTLA4 immunotherapy eradicates chemo-resistant ovarian cancer via tripartite mechanistic synergy

    Journal: Frontiers in Oncology

    doi: 10.3389/fonc.2025.1670033

    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: A2780+Nivolumab+Ipilimumab, A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Figure Legend Snippet: Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: A2780+Nivolumab+Ipilimumab, A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.

    Techniques Used: Control



    Similar Products

    93
    MedChemExpress ipilimumab
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Ipilimumab, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ipilimumab/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    ipilimumab - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Bristol Myers ipilimumab yervoy
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Ipilimumab Yervoy, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ipilimumab yervoy/product/Bristol Myers
    Average 90 stars, based on 1 article reviews
    ipilimumab yervoy - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Bristol Myers anti-ctla4 antibody ipilimumab
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Anti Ctla4 Antibody Ipilimumab, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-ctla4 antibody ipilimumab/product/Bristol Myers
    Average 90 stars, based on 1 article reviews
    anti-ctla4 antibody ipilimumab - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Bristol Myers yervoy® (ipilimumab)
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Yervoy® (Ipilimumab), supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yervoy® (ipilimumab)/product/Bristol Myers
    Average 90 stars, based on 1 article reviews
    yervoy® (ipilimumab) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Agenus Inc vh and vl domains of ipilimumab antibody
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Vh And Vl Domains Of Ipilimumab Antibody, supplied by Agenus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vh and vl domains of ipilimumab antibody/product/Agenus Inc
    Average 90 stars, based on 1 article reviews
    vh and vl domains of ipilimumab antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Pfizer Inc ipilimumab antibody
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Ipilimumab Antibody, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ipilimumab antibody/product/Pfizer Inc
    Average 90 stars, based on 1 article reviews
    ipilimumab antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Bristol Myers nivolumab+ipilimumab
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Nivolumab+Ipilimumab, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nivolumab+ipilimumab/product/Bristol Myers
    Average 90 stars, based on 1 article reviews
    nivolumab+ipilimumab - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Bristol Myers ctla 4 antibodies ipilimumab
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Ctla 4 Antibodies Ipilimumab, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ctla 4 antibodies ipilimumab/product/Bristol Myers
    Average 90 stars, based on 1 article reviews
    ctla 4 antibodies ipilimumab - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Agenus Inc ipilimumab anti-ctla-4 antibody
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Ipilimumab Anti Ctla 4 Antibody, supplied by Agenus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ipilimumab anti-ctla-4 antibody/product/Agenus Inc
    Average 90 stars, based on 1 article reviews
    ipilimumab anti-ctla-4 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Agenus Inc vh and vl domains of ipilimumab
    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: <t>A2780+Nivolumab+Ipilimumab,</t> A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
    Vh And Vl Domains Of Ipilimumab, supplied by Agenus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vh and vl domains of ipilimumab/product/Agenus Inc
    Average 90 stars, based on 1 article reviews
    vh and vl domains of ipilimumab - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: A2780+Nivolumab+Ipilimumab, A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.

    Journal: Frontiers in Oncology

    Article Title: CIK-augmented anti-PD1/CTLA4 immunotherapy eradicates chemo-resistant ovarian cancer via tripartite mechanistic synergy

    doi: 10.3389/fonc.2025.1670033

    Figure Lengend Snippet: Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: A2780+Nivolumab+Ipilimumab, A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.

    Article Snippet: Immune checkpoint inhibitors Nivolumab (HY-P9903, MCE) and Ipilimumab (HY-P9901, MCE); apoptosis and cell cycle detection kits Annexin V-FITC/PI (CA1020, Solarbio) and DNA Content Assay Kit (CA1510, Solarbio); extracellular matrix component Matrigel (356234, Corning); cell viability reagent CCK-8 Kit (CK04, Dojindo); staining agent Crystal Violet (C8470, Solarbio); and fixation solution 4% Paraformaldehyde (G1113, Servicebio).

    Techniques: Control